ACE2-Fc and DPP4-Fc decoy receptors against SARS-CoV-2 and MERS-CoV variants: a quick therapeutic option for current and future coronaviruses outbreaks.
Alfaleh MA, Alsulaiman RM, Almahboub SA, Nezamuldeen L, Zawawi A, Aljehani ND, Yasir M, Abdulal RH, Alkhaldi R, Helal A, Alamri SS, Malki J, Alhabbab RY, Abujamel TS, Alhakamy NA, Alnami A, Algaissi A, Hassanain M, Hashem AM.
Alfaleh MA, et al. Among authors: zawawi a.
Antib Ther. 2023 Dec 12;7(1):53-66. doi: 10.1093/abt/tbad030. eCollection 2024 Jan.
Antib Ther. 2023.
PMID: 38371953
Free PMC article.